JEMEZGO Trademark

Trademark Overview

On Monday, August 2, 2021, a trademark application was filed for JEMEZGO with the United States Patent and Trademark Office. The USPTO has given the JEMEZGO trademark a serial number of 90860812. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, July 25, 2024. This trademark is owned by Celgene Corporation. The JEMEZGO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for use in oncology
jemezgo

General Information

Serial Number90860812
Word MarkJEMEZGO
Filing DateMonday, August 2, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, July 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Thursday, August 5, 2021NEW APPLICATION ENTERED
Tuesday, September 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 31, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, April 29, 2022ASSIGNED TO EXAMINER
Thursday, March 31, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, April 29, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, April 29, 2022EXAMINERS AMENDMENT E-MAILED
Friday, April 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 29, 2022EXAMINER'S AMENDMENT ENTERED
Friday, April 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 31, 2023SOU EXTENSION 1 GRANTED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 31, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 31, 2023SOU EXTENSION 1 FILED
Thursday, February 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 2, 2023SOU EXTENSION 2 GRANTED
Wednesday, August 2, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 2, 2023SOU EXTENSION 2 FILED
Friday, January 12, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 12, 2024SOU EXTENSION 3 FILED
Friday, January 12, 2024SOU EXTENSION 3 GRANTED
Thursday, July 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, July 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2024SOU EXTENSION 4 FILED
Thursday, July 25, 2024SOU EXTENSION 4 GRANTED
Tuesday, January 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

jemezgo oncology human preparations pharmaceutical